The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Open accessAbstract
A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to induce broadly neutralizing antibodies (bNAbs). One approach to the problem is to create trimeric mimics of the native envelope glycoprotein (Env) spike that expose as many bNAb epitopes as possible, while occluding those for non-neutralizing antibodies (non-NAbs). Here, we describe the design and properties of soluble, cleaved SOSIP.664 gp140 trimers based on the subtype A transmitted/founder strain, BG505. These trimers are highly stable, more so even than the corresponding gp120 monomer, as judged by differential scanning calorimetry. They are also homogenous and closely resemble native virus spikes when visualized by negative stain electron microscopy (EM). We used several techniques, including ELISA and surface plasmon resonance (SPR), to determine the relationship between the ability of monoclonal antibodies (MAbs) to bind the soluble trimers and neutralize the corresponding virus. In general, the concordance was excellent, in that virtually all bNAbs against multiple neutralizing epitopes on HIV-1 Env were highly reactive with the BG505 SOSIP.664 gp140 trimers, including quaternary epitopes (CH01, PG9, PG16 and PGT145). Conversely, non-NAbs to the CD4-binding site, CD4-induced epitopes or gp41ECTO did not react with the trimers, even when their epitopes were present on simpler forms of Env (e.g. gp120 monomers or dissociated gp41 subunits). Three non-neutralizing MAbs to V3 epitopes did, however, react strongly with the trimers but only by ELISA, and not at all by SPR and to only a limited extent by EM. These new soluble trimers are useful for structural studies and are being assessed for their performance as immunogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Identification and Analysis Tools on the ExPASy Server
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005) · The Proteomics Protocols Handbook · doi:10.1385/1-59259-890-0:571 · Cited by 8,681
EMAN2: An extensible image processing suite for electron microscopy
Tang, G., Peng, L., Baldwin, P. R., Mann, D. S., Jiang, W., Rees, I., & Ludtke, S. J. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.05.009 · Cited by 2,994
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
EMAN: Semiautomated Software for High-Resolution Single-Particle Reconstructions
Ludtke, S. J., Baldwin, P. R., & Chiu, W. (1999) · Journal of Structural Biology · doi:10.1006/jsbi.1999.4174 · Cited by 2,391
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationA New Generation of the IMAGIC Image Processing System
van Heel, M., Harauz, G., Orlova, E. V., Schmidt, R., & Schatz, M. (1996) · Journal of Structural Biology · doi:10.1006/jsbi.1996.0004 · Cited by 1,228
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Appion: An integrated, database-driven pipeline to facilitate EM image processing
Lander, G. C., Stagg, S. M., Voss, N. R., Cheng, A., Fellmann, D., Pulokas, J., Yoshioka, C., Irving, C., Mulder, A., Lau, P.-W., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.002 · Cited by 835
Molecular architecture of native HIV-1 gp120 trimers
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., & Subramaniam, S. (2008) · Nature · doi:10.1038/nature07159 · Cited by 816
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Self-citationDerdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Self-citationVoss, N. R., Yoshioka, C. K., Radermacher, M., Potter, C. S., & Carragher, B. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.004 · Cited by 570
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Self-citationBinley, J. M., Sanders, R. W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.627-643.2000 · Cited by 534
Self-citationSanders, R. W., Vesanen, M., Schuelke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M., Berkhout, B., Maddon, P. J., Olson, W. C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8875-8889.2002 · Cited by 440
Self-citationGilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V., Self, S. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428405 · Cited by 355
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Kong, L., Lee, J. H., Doores, K. J., Murin, C. D., Julien, J.-P., McBride, R., Liu, Y., Marozsan, A., Cupo, A., Klasse, P.-J., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2594 · Cited by 337
Self-citationJulien, J.-P., Sok, D., Khayat, R., Lee, J. H., Doores, K. J., Walker, L. M., Ramos, A., Diwanji, D. C., Pejchal, R., Cupo, A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003342 · Cited by 293
Self-citationOccupancy and mechanism in antibody-mediated neutralization of animal viruses
Klasse, P. J., & Sattentau, Q. J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2091 · Cited by 287
Self-citationMontefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis367 · Cited by 284
Yang, X., Lee, J., Mahony, E. M., Kwong, P. D., Wyatt, R., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4634-4642.2002 · Cited by 277
Huang, C.-C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M.-Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308527100 · Cited by 275
Wu, X., Parast, A. B., Richardson, B. A., Nduati, R., John-Stewart, G., Mbori-Ngacha, D., Rainwater, S. M. J., & Overbaugh, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.835-844.2006 · Cited by 274
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Julien, J.-P., Lee, J. H., Cupo, A., Murin, C. D., Derking, R., Hoffenberg, S., Caulfield, M. J., King, C. R., Marozsan, A. J., Klasse, P. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217537110 · Cited by 247
Self-citationFerrari, G., Pollara, J., Kozink, D., Harms, T., Drinker, M., Freel, S., Moody, M. A., Alam, S. M., Tomaras, G. D., Ochsenbauer, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00171-11 · Cited by 233
Bonomelli, C., Doores, K. J., Dunlop, D. C., Thaney, V., Dwek, R. A., Burton, D. R., Crispin, M., & Scanlan, C. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023521 · Cited by 230
Mass Spectrometric Characterization of the Glycosylation Pattern of HIV-gp120 Expressed in CHO Cells
Zhu, X., Borchers, C., Bienstock, R. J., & Tomer, K. B. (2000) · Biochemistry · doi:10.1021/bi000432m · Cited by 222
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., & Moss, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3015-3026.1994 · Cited by 215
Sorzano, C. O. S., Bilbao-Castro, J. R., Shkolnisky, Y., Alcorlo, M., Melero, R., Caffarena-Fernández, G., Li, M., Xu, G., Marabini, R., & Carazo, J. M. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.03.011 · Cited by 205
Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H.-X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J.-S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1154-1163.2005 · Cited by 200
Yang, X., Wyatt, R., & Sodroski, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1165-1171.2001 · Cited by 195
Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
Tran, E. E. H., Borgnia, M. J., Kuybeda, O., Schauder, D. M., Bartesaghi, A., Frank, G. A., Sapiro, G., Milne, J. L. S., & Subramaniam, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002797 · Cited by 195
Parren, P. W. H. I., Mondor, I., Naniche, D., Ditzel, H. J., Klasse, P. J., Burton, D. R., & Sattentau, Q. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3512-3519.1998 · Cited by 189
Self-citationHIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
Kovacs, J. M., Nkolola, J. P., Peng, H., Cheung, A., Perry, J., Miller, C. A., Seaman, M. S., Barouch, D. H., & Chen, B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204533109 · Cited by 169
Harris, A., Borgnia, M. J., Shi, D., Bartesaghi, A., He, H., Pejchal, R., Kang, Y. (., Depetris, R., Marozsan, A. J., Sanders, R. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101414108 · Cited by 162
Self-citationYang, X., Farzan, M., Wyatt, R., & Sodroski, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5716-5725.2000 · Cited by 162
Klein, F., Gaebler, C., Mouquet, H., Sather, D. N., Lehmann, C., Scheid, J. F., Kraft, Z., Liu, Y., Pietzsch, J., Hurley, A., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120423 · Cited by 159
Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in Solution
Yang, X., Florin, L., Farzan, M., Kolchinsky, P., Kwong, P. D., Sodroski, J., & Wyatt, R. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4746-4754.2000 · Cited by 156
Pancera, M., & Wyatt, R. T. (2004) · Virology · doi:10.1016/j.virol.2004.10.042 · Cited by 152
Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
Binley, J. Μ., Sanders, R. W., Master, A., Cayanan, C. S., Wiley, C. L., Schiffner, L., Travis, B. M., Kuhmann, S. E., Burton, D. R., Hu, S., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2606-2616.2002 · Cited by 152
Self-citationSchülke, N., Vesanen, M., Sanders, R. W., Zhu, P., Lu, M., Anselma, D. J., Villa, A. R., Parren, P. W. H. I., Binley, J. Μ., Roux, K. H., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7760-7776.2002 · Cited by 149
Self-citationSrivastava, I. K., Stamatatos, L., Kan, E., Vajdy, M., Lian, Y., Hilt, S., Martin, L., Vita, C., Zhu, P., Roux, K. H., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11244-11259.2003 · Cited by 147
Immunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140
Earl, P. L., Sugiura, W., Montefiori, D. C., Broder, C. C., Lee, S. A., Wild, C. T., Lifson, J. D., & Moss, B. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.645-653.2001 · Cited by 140
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
van Gils, M. J., & Sanders, R. W. (2012) · Virology · doi:10.1016/j.virol.2012.10.004 · Cited by 124
Self-citationEnhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
Blish, C. A., Nguyen, M.-A., & Overbaugh, J. M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0050009 · Cited by 98
Influences on Trimerization and Aggregation of Soluble, Cleaved HIV-1 SOSIP Envelope Glycoprotein
Klasse, P. J., Depetris, R. S., Pejchal, R., Julien, J., Khayat, R., Lee, J. H., Marozsan, A. J., Cupo, A., Cocco, N., Korzun, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01226-13 · Cited by 93
Self-citationNkolola, J. P., Peng, H., Settembre, E. C., Freeman, M., Grandpre, L. E., Devoy, C., Lynch, D. M., Porte, A. L., Simmons, N. L., Bradley, R. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02252-09 · Cited by 93
Immunogenicity of HIV-1 envelope glycoprotein oligomers
Forsell, M. N. E., Schief, W. R., & Wyatt, R. T. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832edc19 · Cited by 79
Spearman, P. W., Lally, M., Elizaga, M. L., Montefiori, D. C., Tomaras, G. D., McElrath, M. J., Hural, J., Rosa, S. C. D., Sato, A., Huang, Y., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq175 · Cited by 79
Eggink, D., Melchers, M., Wuhrer, M., van Montfort, T., Dey, A., Naaijkens, B. A., David, K. B., Douce, V. L., Deelder, A. M., Kang, K., et al. (2010) · Virology · doi:10.1016/j.virol.2010.02.019 · Cited by 77
Self-citationStructural Characterization of Cleaved, Soluble HIV-1 Envelope Glycoprotein Trimers
Khayat, R., Lee, J. H., Julien, J., Cupo, A., Klasse, P. J., Sanders, R. W., Moore, J. P., Wilson, I. A., & Ward, A. B. (2013) · Journal of Virology · doi:10.1128/jvi.01222-13 · Cited by 76
Self-citationDetailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors
Eggink, D., Langedijk, J. P. M., Bonvin, A. M. J. J., Deng, Y., Lu, M., Berkhout, B., & Sanders, R. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004416 · Cited by 72
Self-citationHoffenberg, S., Powell, R., Carpov, A., Wagner, D., Wilson, A. J., Pond, S. L. K., Lindsay, R. W. B., Arendt, H. E., DeStefano, J., Phogat, S. K., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02827-12 · Cited by 66
Self-citationKalia, V., Sarkar, S., Gupta, P., & Montelaro, R. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2097-2107.2005 · Cited by 64
Depetris, R. S., Julien, J., Khayat, R., Lee, J. H., Pejchal, R., Katpally, U., Cocco, N., Kachare, M. D., Massi, E., David, K. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371898 · Cited by 51
Self-citationTargeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses
Melchers, M., Bontjer, I., Tong, T., Chung, N. P. Y., Klasse, P. J., Eggink, D., Montefiori, D. C., Gentile, M., Cerutti, A., Olson, W. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06259-11 · Cited by 50
Self-citationEffects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on Antigenicity
Si, Z., Phan, N. M. H., Kiprilov, E., & Sodroski, J. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203763315722 · Cited by 47
Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution
Leaman, D. P., & Zwick, M. B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003184 · Cited by 47
Dey, A., David, K. B., Klasse, P. J., & Moore, J. P. (2006) · Virology · doi:10.1016/j.virol.2006.09.046 · Cited by 45
Self-citationBontjer, I., Land, A., Eggink, D., Verkade, E. J. M., Tuin, K., Baldwin, C. E., Pollakis, G., Paxton, W. A., Braakman, I., Berkhout, B., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01404-08 · Cited by 44
Self-citationDavenport, T. M., Friend, D. J., Ellingson, K., Xu, H., Caldwell, Z., Sellhorn, G., Kraft, Z., Strong, R. K., & Stamatatos, L. (2011) · Journal of Virology · doi:10.1128/jvi.00411-11 · Cited by 43
Finzi, A., Pacheco, B., Zeng, X., Kwon, Y. D., Kwong, P. D., & Sodroski, J. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.05.008 · Cited by 37
Melchers, M., Matthews, K., de Vries, R. P., Eggink, D., van Montfort, T., Bontjer, I., van de Sandt, C. E., David, K. B., Berkhout, B., Moore, J. P., et al. (2011) · Retrovirology · doi:10.1186/1742-4690-8-48 · Cited by 35
Self-citationKong, L., Huang, C.-C., Coales, S. J., Molnar, K. S., Skinner, J., Hamuro, Y., & Kwong, P. D. (2010) · Journal of Virology · doi:10.1128/jvi.00688-10 · Cited by 34
Harris, A. K., Bartesaghi, A., Milne, J. L. S., & Subramaniam, S. (2013) · Journal of Virology · doi:10.1128/jvi.03284-12 · Cited by 30
Dey, A., David, K. B., Lu, M., & Moore, J. P. (2009) · Virology · doi:10.1016/j.virol.2008.12.009 · Cited by 30
Self-citationStabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution
Bontjer, I., Melchers, M., Eggink, D., David, K. B., Moore, J. P., Berkhout, B., & Sanders, R. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.156588 · Cited by 22
Self-citationSanders, R. W., Busser, E., Moore, J. P., Lu, M., & Berkhout, B. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/0889222041524544 · Cited by 22
Self-citation
Cited by
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G., Liu, Y., et al. (2020) · Science · doi:10.1126/science.abd0826 · Cited by 1,303
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science · doi:10.1126/science.abc5902 · Cited by 1,140
Self-citationCrystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., et al. (2013) · Science · doi:10.1126/science.1245625 · Cited by 797
Self-citationPre-fusion structure of a human coronavirus spike protein
Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2016) · Nature · doi:10.1038/nature17200 · Cited by 765
Self-citationQuantitative mass imaging of single biological macromolecules
Young, G., Hundt, N., Cole, D., Fineberg, A., Andrecka, J., Tyler, A., Olerinyova, A., Ansari, A., Marklund, E. G., Collier, M. P., et al. (2018) · Science · doi:10.1126/science.aar5839 · Cited by 753
Metadata
- Authors
- Sanders, R. W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Peña, A. T., Korzun, J., Golabek, M., de los Reyes, K., Ketas, T. J., van Gils, M. J., King, C. R., Wilson, I. A., Ward, A. B., Klasse, P. J., & Moore, J. P.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-19
- Volume
- 9
- Issue
- 9
- Pages
- e1003618
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2083002978
- Cited by
- 935
- References
- 76
- FWCI
- 27.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.